Physician profile
Amanda Dove
NPI 1093978330
$9,428.78
in general payments reported to CMS, 2019-2025
46 companies · $953 in 2025
The $953 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,493 · 2020: $2,144 · 2021: $1,320 · 2022: $1,124 · 2023: $1,052 · 2024: $1,342 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,347.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,787.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,048.58 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $622.96 | 2019-2025 | |
| Abbvie INC. | $621.38 | 2021-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $595.18 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $406.67 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $390.55 | 2019-2025 | Evenity, Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $375.82 | 2019-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $357.71 | 2019-2025 | |
| Allergan, INC. | $334.41 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $324.99 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $290.40 | 2019-2025 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $257.29 | 2021-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $255.46 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.15 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Dove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.